The COVID-19 pandemic and ANCA-associated vasculitis–reports from the EUVAS meeting and EUVAS education forum

A Kronbichler, D Geetha, RM Smith, AC Egan… - Autoimmunity …, 2021 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic influenced the management
of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A paucity …

Current understanding of clinical manifestations of COVID-19 in glomerular disease

A Shimmel, S Shaikhouni, L Mariani - Glomerular diseases, 2021 - karger.com
Background: The novel coronavirus disease (COVID-19), also known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is an evolving pandemic with significant …

Intestinal injury and vasculitis biomarkers in cats with feline enteric coronavirus and effusive feline infectious peritonitis

E Gülersoy, M Ok, K Üney, MK Durgut… - Veterinary Medicine …, 2023 - Wiley Online Library
Objective To investigate intestinal injury, repair and vasculitis biomarkers that may illuminate
the progression and/or pathogenesis of feline infectious peritonitis (FIP) or feline enteric …

[PDF][PDF] COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease

Y Kondo, Y Kaneko, H Takei, H Tamai… - Clin Exp …, 2021 - clinexprheumatol.org
Objective To investigate the similarities and differences between Coronavirus disease 2019
(COVID-19) and autoimmune and autoinflammatory rheumatic diseases characterised by …

Kidneys in SARS‐CoV‐2 era: A challenge of multiple faces

M Abdelsalam, AM Abd El Wahab… - Therapeutic …, 2022 - Wiley Online Library
Introduction With the evolution of SARS‐CoV‐2 pandemic, it was believed to be a direct
respiratory virus. But, its deleterious effects were observed on different body systems …

COVID-19 in patients with glomerular disease

T Turner-Stokes, H Edwards… - Current Opinion in …, 2022 - journals.lww.com
Patients with glomerular disease represent an at-risk group for severe COVID-19 disease
and vaccination is key to reducing this risk. As immunosuppressed patients demonstrate an …

[PDF][PDF] SARS-CoV-2 infection associated with active granulomatosis with polyangiitis

A Masiak, S Nowakowski, Z Zdrojewski - Polish Archives of Internal …, 2021 - academia.edu
FIGurE 1 A–F Computed tomography of the chest showing multiple nodules in both lungs
with cavitation typical of active granulomatosis with polyangiitis (GPA)(white arrows) and …

Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with COVID-19: A Single Center Experience

M Latief, TH Mir, ML Wani - Indian Journal of Nephrology, 2023 - journals.lww.com
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) patients
particularly presenting as rapidly progressive glomerulonephritis (RPGN) are at extremely …

Rheumatological Complications Following COVID-19

RP Goswami, U Kumar - Post COVID-19 Complications and Management, 2022 - Springer
Global data suggest that around 10% of Covid-19 patients remain unwell even after 3
months of getting infection and children are no exception. Several systemic autoimmune and …

Adapted treatment of ANCA-associated vasculitis during the COVID-19 pandemic

A Nimmo, S Risdale - Rheumatology Advances in Practice, 2021 - academic.oup.com
DEAR EDITOR, The ANCA-associated vasculitides (AAV) are multisystem diseases
presenting with wide-ranging symptoms and, frequently, a long prodrome of malaise before …